Akari Therapeutics Plc ADR

AKTXNASDAQ · USD
7.18USD0.00 (+7.01%)
225

Akari Therapeutics Plc ADR (AKTX) Implied Volatility Current

Read more

Tracking AKTX implied volatility helps you spot when Akari Therapeutics Plc ADR options are historically cheap or expensive, and where the best trades are hiding. When AKTX IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor AKTX implied volatility current levels in real time and filter for high probability trades.

Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking AKTX IV rank helps you see whether AKTX's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.

Akari Therapeutics, Plc is a clinical-stage biotechnology firm dedicated to advancing novel treatments for autoimmune and inflammatory disorders. The company's primary investigational therapy is nomacopan, an advanced, second-generation complement inhibitor. This drug is engineered to counteract both inflammatory and prothrombotic processes. Nomacopan holds promise for a range of serious conditions, including paroxysmal nocturnal hemoglobinuria (PNH), Guillain-Barré syndrome (GBS), hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), and bullous pemphigoid (BP). Akari's operations are headquartered in London, United Kingdom.

Implied Volatility

IV Rank
—IV Rank
—
Implied Volatility (30d)316.50%

IV Rank—

Historical Volatility (30d)156.97%

IV Minus HV+159.53%

As of Nov 20, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →